Valvular & structural heart disease
Readmissions after next-day discharge following transcatheter aortic valve implantation
Authors' conclusion
In pacemaker-naïve patients undergoing TF-TAVI with newer-generation THVs, NDD was not associated with a negative impact on overall 30-day readmissions, cardiac or non-cardiac readmissions, readmissions for PPI or HF after discharge, or mortality, regardless of the type of THV.
Study context
- Population
- Pacemaker-naïve patients undergoing transfemoral transcatheter aortic valve implantation (TAVI) discharged the next day without new pacemaker
- Participants
- 963 all-comers
- Exposure
- ACURATE vs Evolut vs SAPIEN transcatheter heart valves (THVs) with next-day discharge after TF-TAVI
- ACURATEn = 264reference
- Evolutn = 306
- SAPIENn = 393
- Outcome
- Unplanned readmissions
- Follow-up
- 30 days
Methodological detailsInverse probability of treatment-weighted (IPTW) propensity-score weighted
- IPTW propensity-score weighted
Main finding
As reported in the abstract
30-day readmissions
Each group vs ACURATERelative risk (95% CI)P value
Evolut
0.76(0.38–1.52)
P = 0.38SAPIEN
0.74(0.44–1.22)
P = 0.28- Overall readmission rate
- 8%
Observational data: associations, not effects.
Further findings
Cardiac readmissions · 30 days
Non-cardiac readmissions · 30 days
Readmission for new pacemaker implantation · 30 days
Readmission for HF · 30 days
- Cardiac readmissions: p=0.56
- Non-cardiac readmissions: p=0.64
- Readmission for new pacemaker implantation: p=0.32
- Readmission for heart failure (HF): p=0.76
Original publication
Readmissions after next-day discharge following transcatheter aortic valve implantation. EuroIntervention. Published 16 December 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →